Canada markets close in 6 hours 30 minutes

Wesana Health Holdings Inc. (WSNAF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.02090.0000 (0.00%)
As of 10:31AM EDT. Market open.

Wesana Health Holdings Inc.

433 W Van Buren Street
Suite 200
Chicago, IL 60607
United States
773 236 7972
https://www.wesanahealth.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Daniel CarcilloCo-Founder, CEO & Chairman444.2kN/A1985
Mr. Chad BronsteinCo-Founder126.35kN/A1988
Dr. Mark A. Wingertzahn Ph.D.Chief Scientific Officer402.26kN/A1972
Mr. Zed WangCorporate Secretary207.53kN/A1989
Mr. Keenan GentryVice President of Investor Relations & Corporate DevelopmentN/AN/AN/A
Izzy FormanVice President of CommunicationsN/AN/AN/A
Mr. Jeffrey T. JewellSenior Vice President of Medical & Scientific AffairsN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Wesana Health Holdings Inc. does not have significant operations. Previously, it was developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma. The company is headquartered in Chicago, Illinois.

Corporate Governance

Wesana Health Holdings Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.